The Annual Product Quality Review is not a voluntary best practice. It is a formal regulatory requirement under multiple international frameworks including FDA 21 CFR 211.180(e), EU GMP Chapter 1 Section 1.10, ICH Q7 Section 2.5 and ICH Q10 Section 3.2.3. For products sold in multiple markets the most prescriptive framework applies and EU GMP Chapter 1 is significantly more demanding than the FDA baseline.

This course covers what the APQR must contain, how to analyse the data and what FDA and EU GMP inspectors consistently find when they review an APQR during inspection. It explains the difference between the FDA Annual Product Review and the EU Product Quality Review - same regulatory requirement, different terminology and different content obligations.

The course covers the mandatory data elements under both frameworks including the EU GMP-specific requirements for process consistency verification, Cpk analysis, supplier quality review and revalidation assessment. You will learn how to conduct meaningful trend analysis of batch data, OOS results, stability data and complaint patterns and why presenting raw data without trend analysis does not satisfy the regulatory requirement for a meaningful evaluation.

The course covers timing, ownership, approval and record retention requirements and closes with the four most common APQR inspection findings from FDA and EU GMP inspections including the most cited finding of all - raw data presented without trend analysis or actionable conclusions.

Built from FDA 21 CFR 211.180(e), EU GMP Chapter 1 Section 1.10, ICH Q7, ICH Q10 Section 3.2.3 and WHO TRS 986. Audience: Quality assurance managers, quality directors, regulatory affairs professionals and anyone responsible for preparing, reviewing or approving the annual product quality review.